Preservation HIV-1-specific IFNγ+ CD4+ T-cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trial
about
Changes in Natural Killer cell activation and function during primary HIV-1 Infection.HIV disease progression in seroconvertors from the CAPRISA 004 tenofovir gel pre-exposure prophylaxis trialNo evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial.Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses.Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxisDistinct genital tract HIV-specific antibody profiles associated with tenofovir gel.Neither microbial translocation nor TLR responsiveness are likely explanations for preexisting immune activation in women who subsequently acquired HIV in CAPRISA 004From the laboratory to clinical trials and back again: lessons learned from HIV prevention trials.Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide.
P2860
Q34551274-B72AAEDA-019A-472C-8FDD-B3E576C19C71Q34674930-B6CA1D32-E335-42E9-8A3D-C98FF003D21AQ34981309-A2087E5A-1317-42A1-B7D8-0364F7AD9409Q35798274-05A41BEC-67CE-4826-BA98-040A1EA594E6Q36379277-1F593067-0BF4-42AA-B2E7-D174F2238B1CQ36844746-DEF1B88B-D11C-4FFC-9BE0-DA78122C3B1AQ36930494-97EAE18B-50A2-4408-AD6B-2158057AAC23Q38067443-2750C871-C75F-497D-A35E-E998730E7A72Q38644317-9B413FA6-2BD5-4899-BF2E-7F3415D3165A
P2860
Preservation HIV-1-specific IFNγ+ CD4+ T-cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trial
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Preservation HIV-1-specific IF ...... CAPRISA 004 microbicide trial
@ast
Preservation HIV-1-specific IF ...... CAPRISA 004 microbicide trial
@en
type
label
Preservation HIV-1-specific IF ...... CAPRISA 004 microbicide trial
@ast
Preservation HIV-1-specific IF ...... CAPRISA 004 microbicide trial
@en
prefLabel
Preservation HIV-1-specific IF ...... CAPRISA 004 microbicide trial
@ast
Preservation HIV-1-specific IF ...... CAPRISA 004 microbicide trial
@en
P2093
P2860
P50
P1476
Preservation HIV-1-specific IF ...... CAPRISA 004 microbicide trial
@en
P2093
CAPRISA004 Trial Group
Danielle Poole
Marianne W Mureithi
Nompumelelo P Mkhwanazi
Shabashini Reddy
P2860
P304
P356
10.1097/QAI.0B013E31824F53A9
P407
P50
P577
2012-06-01T00:00:00Z